This page includes the latest FDA filings for Nova Laboratories L T D. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| Registration Number | 3005813646 |
| FEI Number | 3000323524 |
| Name | NOVA LABORATORIES LIMITED |
| Owner & Operator | Nova Laboratories Limited |
| Contact Address | Martin House Gloucester Crescent Wigston GB-LEC Leicestershire LE18 4YL GB |
| Official Correspondent |
|
| US Agent |
|
| Registration Status | 1 |
| Initial Importer | N |
| Registration Expiration | 2020-04-25 |
| Registration Address | Martin House Gloucester Crescent Wigston Leicestershire, LE18 4YL GB |
| Establishment Type | Manufacture Medical Device for Another Party (Contract Manufacturer) |
Device Company | Device | Date |
|---|---|---|
| Spark Therapeutics, Inc., PPD Development, LP. (Middleton, WI Laboratory), Absorption Systems, Eurofins Lancaster Laboratories, Inc, Intertek USA Inc, Nova Laboratories Ltd, Catalent CTS (Edinburgh) Limited, Tepnel Pharma Services Limited, Synergy Health Sterilisa | Prescription Medication | 2026-01-16 |
| Spark Therapeutics, Inc., PPD Development, LP. (Middleton, WI Laboratory), Absorption Systems, Eurofins Lancaster Laboratories, Inc, Intertek USA Inc, Nova Laboratories Ltd, Catalent CTS (Edinburgh) Limited, Tepnel Pharma Services Limited, Synergy Health Sterilisa | Prescription Medication | 2026-01-11 |
| Nova Laboratories, Ltd, Rare Disease Therapeutics, Inc. | Prescription Medication | 2025-12-10 |
| Nova Laboratories, Ltd, Rare Disease Therapeutics, Inc. | Prescription Medication | 2025-09-10 |
| Nova Laboratories, Ltd, Rare Disease Therapeutics, Inc. | Prescription Medication | 2025-08-22 |
| Nova Laboratories, Ltd., Rare Disease Therapeutics, Inc., Nova Laboratories, Ltd | Prescription Medication | 2025-08-22 |
| Nova Laboratories, Ltd, Rare Disease Therapeutics, Inc. | Prescription Medication | 2025-06-13 |
| Nova Laboratories, Ltd., Rare Disease Therapeutics, Inc., Nova Laboratories, Ltd | Prescription Medication | 2025-01-05 |
| Nova Laboratories, Ltd., Rare Disease Therapeutics, Inc., Nova Laboratories, Ltd | Prescription Medication | 2024-10-30 |
| Nova Laboratories, Ltd, Rare Disease Therapeutics, Inc. | Prescription Medication | 2024-10-27 |
| Nova Laboratories, Ltd., Rare Disease Therapeutics, Inc., Nova Laboratories, Ltd | Prescription Medication | 2024-10-23 |
| Nova Laboratories, Ltd, Rare Disease Therapeutics, Inc. | Prescription Medication | 2024-07-11 |
| Nova Laboratories, Ltd, Rare Disease Therapeutics, Inc. | Prescription Medication | 2024-05-02 |
| Spark Therapeutics, Inc., PPD Development, LP. (Middleton, WI Laboratory), Absorption Systems, Eurofins Lancaster Laboratories, Inc, Intertek USA Inc, Nova Laboratories Ltd, Catalent CTS (Edinburgh) Limited, Tepnel Pharma Services Limited, Synergy Health Sterilisa | Prescription Medication | 2024-04-18 |
| Nova Laboratories, Ltd., Rare Disease Therapeutics, Inc., Nova Laboratories, Ltd | Prescription Medication | 2024-04-10 |
| Nova Laboratories, Ltd, Rare Disease Therapeutics, Inc. | Prescription Medication | 2022-10-12 |
| Spark Therapeutics, Inc., PPD Development, LP. (Middleton, WI Laboratory), Absorption Systems, Eurofins Lancaster Laboratories, Inc, Intertek USA Inc, Nova Laboratories Ltd, Catalent CTS (Edinburgh) Limited, Tepnel Pharma Services Limited, Synergy Health Sterilisa | Prescription Medication | 2022-06-24 |
| Nova Laboratories, Ltd, Rare Disease Therapeutics, Inc. | Prescription Medication | 2020-04-15 |
| Spark Therapeutics, Inc., PPD Development, LP. (Middleton, WI Laboratory), Absorption Systems, Eurofins Lancaster Laboratories, Inc, Intertek USA Inc, Nova Laboratories Ltd, Catalent CTS (Edinburgh) Limited, Tepnel Pharma Services Limited, Synergy Health Sterilisa | Prescription Medication | 2020-01-15 |
| Spark Therapeutics, Inc., PPD Development, LP. (Middleton, WI Laboratory), Absorption Systems, Eurofins Lancaster Laboratories, Inc, Intertek USA Inc, Nova Laboratories Ltd, Catalent CTS (Edinburgh) Limited, Tepnel Pharma Services Limited, Synergy Health Sterilisa | Prescription Medication | 2019-09-25 |
| Spark Therapeutics, Inc., PPD Development, LP. (Middleton, WI Laboratory), Absorption Systems, Eurofins Lancaster Laboratories, Inc, Intertek USA Inc, Nova Laboratories Ltd, Catalent CTS (Edinburgh) Limited, Tepnel Pharma Services Limited, Synergy Health Sterilisa | Prescription Medication | 2019-06-26 |
| Nova Laboratories, Ltd, Rare Disease Therapeutics, Inc. | Prescription Medication | 2019-04-10 |
NOVA LABORATORIES LIMITED | Magtrace | 2018-09-27 |
| Nova Laboratories, Ltd | PURIXAN | 2014-04-28 |
| NCAGE Code | KA249 | NOVA LABORATORIES LTD |
| CAGE Code | KA249 | NOVA LABORATORIES LTD |